164 related articles for article (PubMed ID: 31007740)
1. Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models.
Wang D; Lu J; Li Q; Li Z
Exp Ther Med; 2019 May; 17(5):4023-4031. PubMed ID: 31007740
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporin population pharmacokinetics in pediatric refractory nephrotic syndrome based on real-world studies: Effects of body weight and spirolactone administration.
Wang D; Chen X; Li Z
Exp Ther Med; 2019 Apr; 17(4):3015-3020. PubMed ID: 30936972
[TBL] [Abstract][Full Text] [Related]
3. Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome.
Li L; Zhu M; Li DY; Guo HL; Hu YH; Xu ZY; Jing X; Chen F; Zhao F; Li YM; Xu J; Jiao Z
Int Immunopharmacol; 2021 Sep; 98():107827. PubMed ID: 34284341
[TBL] [Abstract][Full Text] [Related]
4. Dosage optimization of tacrolimus based on the glucocorticoid dose and pharmacogenetics in adult patients with systemic lupus erythematosus.
Wang CB; Zhang YJ; Zhao MM; Zhao L
Int Immunopharmacol; 2023 Nov; 124(Pt A):110866. PubMed ID: 37678026
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics and dosage optimization of tacrolimus in pediatric patients with nephrotic syndrome
.
Wang X; Han Y; Chen C; Ma L; Xiao H; Zhou Y; Cui Y; Wang F; Su B; Yao Y; Ding J
Int J Clin Pharmacol Ther; 2019 Mar; 57(3):125-134. PubMed ID: 30663980
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model.
Huang L; Liu Y; Jiao Z; Wang J; Fang L; Mao J
Eur J Pharm Sci; 2020 Feb; 143():105199. PubMed ID: 31862313
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus pharmacokinetics in pediatric nephrotic syndrome: A combination of population pharmacokinetic modelling and machine learning approaches to improve individual prediction.
Huang Q; Lin X; Wang Y; Chen X; Zheng W; Zhong X; Shang D; Huang M; Gao X; Deng H; Li J; Zeng F; Mo X
Front Pharmacol; 2022; 13():942129. PubMed ID: 36457704
[No Abstract] [Full Text] [Related]
8. Population pharmacokinetics of sirolimus in pediatric patients with kaposiform hemangioendothelioma: A retrospective study.
Wang D; Chen X; Li Z
Oncol Lett; 2019 Sep; 18(3):2412-2419. PubMed ID: 31452734
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study.
Wang DD; Lu JM; Li Q; Li ZP
J Clin Pharm Ther; 2018 Aug; 43(4):476-483. PubMed ID: 29766530
[TBL] [Abstract][Full Text] [Related]
11. [Population pharmacokinetics of lamotrigine in Chinese children with epilepsy].
Zhang S; Wang L; Lu W
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):105-9. PubMed ID: 18433522
[TBL] [Abstract][Full Text] [Related]
12. The first study in pediatric: Population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia.
Cheng X; Zhao Y; Gu H; Zhao L; Zang Y; Wang X; Wu R
Int J Immunopathol Pharmacol; 2020; 34():2058738420934936. PubMed ID: 32720540
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation.
Wei Y; Wu D; Chen Y; Dong C; Qi J; Wu Y; Cai R; Zhou S; Li C; Niu L; Wu T; Xiao Y; Liu T
Front Pharmacol; 2022; 13():1002628. PubMed ID: 36313303
[No Abstract] [Full Text] [Related]
14. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation.
Guy-Viterbo V; Scohy A; Verbeeck RK; Reding R; Wallemacq P; Musuamba FT
Eur J Clin Pharmacol; 2013 Aug; 69(8):1533-42. PubMed ID: 23588560
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and dose simulation of cyclosporine in Chinese children with nephrotic syndrome: Effects of weight and total cholesterol.
Zhao Y; He H; Zang Y; Zhao L; Wang X
Int J Clin Pharmacol Ther; 2022 Feb; 60(2):87-96. PubMed ID: 34753558
[TBL] [Abstract][Full Text] [Related]
17. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].
Xue L; Rui JZ; Zhang Y; Miao LY
Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140
[TBL] [Abstract][Full Text] [Related]
18. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
Musuamba FT; Mourad M; Haufroid V; Delattre IK; Verbeeck RK; Wallemacq P
Ther Drug Monit; 2009 Dec; 31(6):734-42. PubMed ID: 19855314
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus Population Pharmacokinetic Model in Adult Chinese Patients with Nephrotic Syndrome and Dosing Regimen Identification Using Monte Carlo Simulations.
Liao M; Wang M; Zhu X; Zhao L; Zhao M
Ther Drug Monit; 2022 Oct; 44(5):615-624. PubMed ID: 36101928
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts.
Yoshida S; Fujimoto A; Fukushima K; Ando M; Irie K; Hirano T; Miyasaka M; Shimomura Y; Ishikawa T; Ikesue H; Muroi N; Hashida T; Sugioka N
J Clin Pharm Ther; 2021 Feb; 46(1):190-197. PubMed ID: 33090593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
